38 related articles for article (PubMed ID: 12467221)
1. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
Chen R; Wierda WG; Chubb S; Hawtin RE; Fox JA; Keating MJ; Gandhi V; Plunkett W
Blood; 2009 May; 113(19):4637-45. PubMed ID: 19234140
[TBL] [Abstract][Full Text] [Related]
3. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.
Chen R; Keating MJ; Gandhi V; Plunkett W
Blood; 2005 Oct; 106(7):2513-9. PubMed ID: 15972445
[TBL] [Abstract][Full Text] [Related]
4. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.
Wang J; Walsh K
Science; 1996 Jul; 273(5273):359-61. PubMed ID: 8662523
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.
Li X; Lu J; Kan Q; Li X; Fan Q; Li Y; Huang R; Slipicevic A; Dong HP; Eide L; Wang J; Zhang H; Berge V; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Sci Rep; 2017 Jul; 7(1):5081. PubMed ID: 28698547
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D3 activates Caspase 2, connecting cell proliferation with cell death.
Mendelsohn AR; Hamer JD; Wang ZB; Brent R
Proc Natl Acad Sci U S A; 2002 May; 99(10):6871-6. PubMed ID: 12011445
[TBL] [Abstract][Full Text] [Related]
7. Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy.
Kadia TM; Kantarjian HM; Konopleva M
Oncotarget; 2019 Feb; 10(12):1250-1265. PubMed ID: 30815228
[TBL] [Abstract][Full Text] [Related]
8. Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis.
Pulliam SR; Pellom ST; Shanker A; Adunyah SE
Cytokine; 2016 Aug; 84():74-87. PubMed ID: 27253488
[TBL] [Abstract][Full Text] [Related]
9. Update on rational targeted therapy in AML.
Shafer D; Grant S
Blood Rev; 2016 Jul; 30(4):275-83. PubMed ID: 26972558
[TBL] [Abstract][Full Text] [Related]
10. Rational Combinations of Targeted Agents in AML.
Bose P; Grant S
J Clin Med; 2015 Apr; 4(4):634-664. PubMed ID: 26113989
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors.
Zhang Z; Hao C; Wang L; Liu P; Zhao L; Zhu C; Tian X
Onco Targets Ther; 2013; 6():733-40. PubMed ID: 23836985
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.
Bose P; Simmons GL; Grant S
Expert Opin Investig Drugs; 2013 Jun; 22(6):723-38. PubMed ID: 23647051
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
Holkova B; Supko JG; Ames MM; Reid JM; Shapiro GI; Perkins EB; Ramakrishnan V; Tombes MB; Honeycutt C; McGovern RM; Kmieciak M; Shrader E; Wellons MD; Sankala H; Doyle A; Wright J; Roberts JD; Grant S
Clin Cancer Res; 2013 Apr; 19(7):1873-83. PubMed ID: 23515411
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifiers: basic understanding and clinical development.
Piekarz RL; Bates SE
Clin Cancer Res; 2009 Jun; 15(12):3918-26. PubMed ID: 19509169
[TBL] [Abstract][Full Text] [Related]
16. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.
Rosato RR; Almenara JA; Maggio SC; Coe S; Atadja P; Dent P; Grant S
Mol Cancer Ther; 2008 Oct; 7(10):3285-97. PubMed ID: 18852132
[TBL] [Abstract][Full Text] [Related]
17. Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium.
Hussain SR; Lucas DM; Johnson AJ; Lin TS; Bakaletz AP; Dang VX; Viatchenko-Karpinski S; Ruppert AS; Byrd JC; Kuppusamy P; Crouser ED; Grever MR
Blood; 2008 Mar; 111(6):3190-9. PubMed ID: 18192508
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01.
Yeow WS; Ziauddin MF; Maxhimer JB; Shamimi-Noori S; Baras A; Chua A; Schrump DS; Nguyen DM
Br J Cancer; 2006 May; 94(10):1436-45. PubMed ID: 16705314
[TBL] [Abstract][Full Text] [Related]
19. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.
Fandy TE; Shankar S; Ross DD; Sausville E; Srivastava RK
Neoplasia; 2005 Jul; 7(7):646-57. PubMed ID: 16026644
[TBL] [Abstract][Full Text] [Related]
20. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.
Rust R; Harms G; Blokzijl T; Boot M; Diepstra A; Kluiver J; Visser L; Peh SC; Lim M; Kamps WA; Poppema S; van den Berg A
J Clin Pathol; 2005 May; 58(5):520-4. PubMed ID: 15858125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
